
Ruiping Dong
Chief Medical Expert
MD, Kyushu University, Japan; Postdoctoral Fellow, Harvard Medical School; Medical Director, Oncology Clinical Research, AstraZeneca; Global VP, China/Japan R&D, Bristol-Myers Squibb; Global SVP, Emerging Markets R&D, Merck. Designated expert under China's Thousand Talents Plan; recognized expert under Jiangsu Province's Mass Entrepreneurship and Innovation Program; expert under the China Medical City 113 Talents Program.

Tiehan Jin
President
EMBA, Peking University; PhD in Clinical Psychology, Institute of Psychology, Chinese Academy of Sciences. Undergraduate degree in clinical medicine; practiced as a clinician for many years; trained in the rehabilitation department of the Third Hospital of Beijing Medical University. Previously served as Chairman of Beijing Chengkang Company and Beijing American-Asia Longitudinal Company. Over 20 years of deep involvement in the medical device industry, with longstanding partnerships with DJO and other globally recognized rehabilitation equipment manufacturers.

Guixiang Wang
Vice President
8 years as a senior engineer at Sharp, BSH, and other major global enterprises. Over 10 years of experience in R&D and management of medical and electronic products.

Wei Zhan
Deputy General Manager and R&D Director
B.S. in Electronic Information Science and Technology, Xuzhou Institute of Technology. Over 10 years of experience in medical device R&D and management. Has collaborated with leading international experts, bringing extensive medical device development experience.